KESIMPTA (ofatumumab) injection

KESIMPTA (ofatumumab) injection

KESIMPTA

ofatumumab

20 mg/0.4 mL solution in a single-dose prefilled Sensoready® pen / 20 mg/0.4 mL solution in a single-dose prefilled syringe

Novartis Pharmaceuticals Corporation

Medical Use

KESIMPTA is a prescription medication designed to treat adults with relapsing forms of multiple sclerosis (MS). This includes clinically isolated syndrome (CIS), relapsing-remitting MS, and active secondary progressive